文献速递泌尿生殖技术与安全PET

癌症诊疗一体化临床试验及其近期临床实践潜在影响

Clinical trials in cancer theranostics with potential near-term impact on clinical practice.
PubMed 文献 · Br J Radiol · 2026-01-01

本文综述了针对前列腺特异性膜抗原、胃泌素释放肽受体和成纤维细胞激活蛋白的活跃招募期2期和3期癌症诊疗一体化临床试验,预计这些试验结果将在近期(<5年)影响临床实践。文中提及配对影像与放射性药物治疗药物已在胃肠胰神经内分泌肿瘤和转移性去势抵抗性前列腺癌中获监管批准并常规使用。

要点

  • 针对PSMA、GRPR和FAP的2/3期诊疗一体化试验正在进行中。
  • 配对影像与放射性药物治疗已用于胃肠胰神经内分泌肿瘤和转移性去势抵抗性前列腺癌。
  • 多靶点诊疗一体化可能提供协同疗效以应对肿瘤异质性。

核心结论

  • 针对PSMA、GRPR和FAP的活跃招募2期和3期诊疗一体化临床试验预计近期(<5年)影响临床实践。

研究设计与样本

  • 综述,检索并汇总当前活跃招募的癌症诊疗一体化2期和3期临床试验。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Theranostics has its roots with the first radioiodine therapy for thyroid diseases in about 80 years ago. More recently the field has experienced a remarkable renascence with the regulatory approval of paired imaging and radiopharmaceutical therapy agents in gastroenteropancreatic neuroendocrine tumours and metastatic castration-resistant prostate cancer that are now employed in routine clinical practice. The momentum is strong for identification and testing of new theranostic agents for use in various cancers and finding new clinical indications of the available agents. There are currently numerous preclinical, first-in-human studies, large-scale prospective registries, and clinical trials including randomized trials underway in cancer theranostics that target a variety of germane biological targets. The results of these investigations, if successful, will undoubtedly impact the future of cancer management which is anticipated to improve patient outcome. Multi-targeted theranostics may also provide opportunities for synergistic efficacy to tackle the inherent complexities driven by the heterogeneity of cancer. In this article, we review the currently active recruiting phase 2 and phase 3 clinical trials in cancer theranostics that are targeted to the prostate-specific membrane antigen, gastrin-releasing peptide receptor, and fibroblast activation protein, with the anticipated potential near-term (<5 years) impact on clinical practice.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Jadvar H, Doroudinia A, Conti PS, et al. Clinical trials in cancer theranostics with potential near-term impact on clinical practice. Br J Radiol. 2026. PMID: 39873742. doi:10.1093/bjr/tqaf017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。